Videos | Congenital Heart

Example of GE Healthcare’s FetalHQ software for the ultrasound imaging of fetal hearts. The new tool runs on GE ...

Home November 01, 2018
Home
News | Cardiovascular Ultrasound

Vygon, an international group specialized in single-use medical devices, and French company Sonoscanner announced the design and development of the VysionXS, a new ultrasound scanner dedicated to vascular access catheterization guidance.

Home October 31, 2018
Home
News | Pharmaceuticals

Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects of Repatha (evolocumab) in patients with established cardiovascular disease by kidney function. In line with previous FOURIER subgroup analyses, these results further demonstrate Repatha's efficacy in reducing not only low-density lipoprotein cholesterol (LDL-C) levels, but also the relative risk for major cardiovascular events such as heart attack and stroke, in high-risk patients including those with mild-to-moderate chronic kidney disease (CKD).1-4 In these patients (N=4,443), absolute reductions tended to be greater in the risk for the composite secondary endpoint which included cardiovascular death, heart attack or stroke. Adverse events were similar across patients regardless of CKD stage and consistent with the Repatha known safety profile.

Home October 31, 2018
Home
News | Stroke

Recent statin and medication advances have led some researchers to suggest surgical treatments for carotid stenosis should be limited to symptomatic patients ­– primarily those who have already had a stroke or TIA. However, a new study published in the Journal of Vascular Surgery questions whether medical therapy is a sufficient stroke-reduction strategy.

Home October 31, 2018
Home
Cardiac Ultrasound Software Streamlines Fetal Heart Exams
Feature | Congenital Heart

A new tool called fetalHQ on GE Healthcare’s Voluson ultrasound systems is the first tool to simultaneously examine the size, shape and function of the fetal heart.

Home October 30, 2018
Home
News | Cybersecurity

The U.S. Food and Drug Administration (FDA) and the U.S. Department of Homeland Security (DHS) will be implementing a new framework for greater coordination and cooperation between the two agencies for addressing medical device cybersecurity. The partnership is part of a memorandum of agreement the two agencies issued this month.

Home October 30, 2018
Home
News | Hypertension

Blood pressure readings of 130/80 millimeters of mercury (mmHg) or higher taken at home can be used to diagnose hypertension in white, black and Hispanic U.S. adults, according to new research in the American Heart Association’s journal Hypertension.

Home October 29, 2018
Home
News | Heart Failure

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is pausing the CONCERT-HF trial, which involves patients with chronic heart failure. Recent calls for the retraction of journal articles in related fields of cell therapy research have raised concerns about the scientific foundations of this trial, according to the NHLBI.

Home October 29, 2018
Home
News | EP Mapping and Imaging Systems

October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto ...

Home October 29, 2018
Home
News | Cardiovascular Ultrasound

Hitachi Healthcare Americas participated in the cardiovascular screening and diagnostic triage event that took place across four clinical sites in the greater Morgantown, W. V. on Oct. 20, 2018. This event provided 375 rural patients a resource for diagnostic screening not normally available in their region.

Home October 29, 2018
Home
News | Blood Testing

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient's side in as little as 15 minutes could identify nearly three-fifths (56.7 percent) of people at low risk of experiencing a heart attack. The results are similar to the results of a High Sensitive Troponin-I blood test done in the laboratory setting.

Home October 26, 2018
Home
News | Stethoscopes

Eko, creators of a machine learning-based heart and lung monitoring platform, announced a collaboration with Mayo Clinic to develop a data-driven technology to help physicians detect potentially dangerous heart diseases that may otherwise be missed. The two entities will work together to develop and commercialize a machine learning-based algorithm with a smart digital stethoscope that screens patients for the presence of a low ejection fraction. Once identified, evidence-based treatments are available that prolong life and reduce the risk of symptoms.

Home October 26, 2018
Home
News | Cardiovascular Business

Overall cardiology compensation has dropped for the first time since 2014, according to the sixth annual Cardiovascular Provider Compensation & Production Survey from MedAxiom. In addition, the survey found the income gap between private and integrated groups widened in 2017.

Home October 25, 2018
Home
News | Cardiovascular Surgery

October 25, 2018 — On Oct. 18, 2018, LivaNova issued a Medical Device Correction letter to inform customers of actions ...

Home October 25, 2018
Home
Sponsored Content | Feature | Sudden Cardiac Arrest

Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to participate in competitive sports. One purpose of the PPE is to check for any underlying cardiovascular abnormalities that could put an athlete at risk for sudden cardiac arrest (SCA), which is the number one medical cause of death in young athletes.

Home October 25, 2018
Home
Subscribe Now